What is the role of CTCs?

Date

10 Oct 2016

Session

Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Presenters

Howard Scher

Authors

H. Scher

Author affiliations

  • Medicine, Memorial Sloan-Kettering Cancer Center, 10065 - New York/US
More

Resources

Resources from the same session

Introduction

Presenter: David Olmos

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Webcast

Conclusions and clinical perspectives

Presenter: Felix Feng

Session: Biomarker strategies to improve the treatment of castration-resistant prostate cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings